Yeramian Patrick D
Insider CIK 1358266 · AMLX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-01-09 | 2024-01-11 | 2,812 | $16.33 | $45.9K | 205,605 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-05-15 | 2023-05-17 | 2,201 | — | $0 | 15,404 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-05-15 | 2023-05-17 | 9,764 | — | $0 | 33,770 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-05-15 | 2023-05-17 | 9,764 | $6.88 | $67.2K | 220,382 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-05-15 | 2023-05-17 | 11,965 | $29.03 | $347.3K | 208,417 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-05-15 | 2023-05-17 | 2,201 | $0.37 | $814 | 210,618 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-04-17 | 2023-04-19 | 44,861 | — | $0 | 17,605 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-04-17 | 2023-04-19 | 4,718 | — | $0 | 43,534 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-04-17 | 2023-04-19 | 4,718 | $6.88 | $32.5K | 257,996 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-04-17 | 2023-04-19 | 44,861 | $0.37 | $16.6K | 253,278 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-04-17 | 2023-04-19 | 49,279 | $30.53 | $1.50M | 208,717 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-04-17 | 2023-04-19 | 300 | $30.94 | $9.3K | 208,417 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-20 | 41,250 | — | $0 | 41,250 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-24 | 41,250 | — | $0 | 41,250 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-03-16 | 2023-03-24 | 2,789 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-03-16 | 2023-03-24 | 16,748 | — | $0 | 48,252 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2023-03-16 | 2023-03-24 | 30,041 | — | $0 | 62,466 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 2,416 | $32.43 | $78.4K | 149,672 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 52,211 | $31.85 | $1.66M | 152,088 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-20 | 9,167 | — | $0 | 158,839 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-03-16 | 2023-03-24 | 30,041 | $0.37 | $11.1K | 237,129 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-03-16 | 2023-03-24 | 16,748 | $6.88 | $115.2K | 253,877 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-24 | 52,211 | $31.85 | $1.66M | 201,666 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2023-03-16 | 2023-03-24 | 2,789 | $0.33 | $920 | 207,088 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-24 | 2,416 | $32.43 | $78.4K | 199,250 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-24 | 9,167 | — | $0 | 208,417 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 1,405 | $36.08 | $50.7K | 204,928 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 629 | $36.79 | $23.1K | 204,299 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 127,500 | — | $0 | 127,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2022-01-06 | 2022-01-10 | 28,333 | — | $0 | 206,333 | SEC↗ |